These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Comparison of gadolinium Cy2DOTA, a new hepatobiliary agent, and gadolinium HP-DO3A, an extracellular agent, in healthy liver and metastatic disease. Runge VM; Wells JW; Williams NM Invest Radiol; 1995 Feb; 30(2):123-30. PubMed ID: 7782188 [TBL] [Abstract][Full Text] [Related]
23. CT and MR imaging of the liver using liver-specific contrast media. A comparative study in a tumour model. Leander P; Månsson S; Ege T; Besjakov J Acta Radiol; 1996 May; 37(3 Pt 1):242-9. PubMed ID: 8845249 [TBL] [Abstract][Full Text] [Related]
24. Hepatic abscesses. Magnetic resonance imaging findings using gadolinium-BOPTA. Runge VM; Wells JW; Williams NM Invest Radiol; 1996 Dec; 31(12):781-8. PubMed ID: 8970881 [TBL] [Abstract][Full Text] [Related]
25. Metalloporphyrin contrast enhancement of tumors in magnetic resonance imaging. A study of human carcinoma, lymphoma, and fibrosarcoma in mice. Ogan MD; Revel D; Brasch RC Invest Radiol; 1987 Oct; 22(10):822-8. PubMed ID: 3429177 [TBL] [Abstract][Full Text] [Related]
26. The uptake of manganese dipyridoxal-diphosphate by chemically induced hepatocellular carcinoma in rats. A correlation between contrast-media-enhanced magnetic resonance imaging, tumor differentiation, and vascularization. Ni Y; Marchal G; Zhang X; Van Hecke P; Michiels J; Yu J; Rummeny E; Lodemann KP; Baert AL Invest Radiol; 1993 Jun; 28(6):520-8. PubMed ID: 8320070 [TBL] [Abstract][Full Text] [Related]
27. Hepatic tumor detection: MR imaging and conventional US versus pulse-inversion harmonic US of NC100100 during its reticuloendothelial system-specific phase. Forsberg F; Piccoli CW; Liu JB; Rawool NM; Merton DA; Mitchell DG; Goldberg BB Radiology; 2002 Mar; 222(3):824-9. PubMed ID: 11867808 [TBL] [Abstract][Full Text] [Related]
28. Synthesis, characterization, and imaging performance of a new class of macrocyclic hepatobiliary MR contrast agents. Marinelli ER; Neubeck R; Song B; Wagler T; Ranganathan RS; Sukumaran K; Wedeking PW; Nunn A; Runge VM; Tweedle MF Invest Radiol; 2000 Jan; 35(1):8-24. PubMed ID: 10639032 [TBL] [Abstract][Full Text] [Related]
29. Mangafodipir trisodium (MnDPDP)-enhanced magnetic resonance imaging of the liver and pancreas. Wang C Acta Radiol Suppl; 1998; 415():1-31. PubMed ID: 9571956 [TBL] [Abstract][Full Text] [Related]
30. Mn(2+)-doped silica nanoparticles for hepatocyte-targeted detection of liver cancer in T1-weighted MRI. Kim SM; Im GH; Lee DG; Lee JH; Lee WJ; Lee IS Biomaterials; 2013 Nov; 34(35):8941-8. PubMed ID: 23973173 [TBL] [Abstract][Full Text] [Related]
31. Development of Bifunctional Gadolinium-Labeled Superparamagnetic Nanoparticles (Gd-MnMEIO) for In Vivo MR Imaging of the Liver in an Animal Model. Kuo YT; Chen CY; Liu GC; Wang YM PLoS One; 2016; 11(2):e0148695. PubMed ID: 26886558 [TBL] [Abstract][Full Text] [Related]
33. Comparison between Gd-DTPA, Gd-EOB-DTPA, and Mn-DPDP in induced HCC in rats: a correlation study of MR imaging, microangiography, and histology. Marchal G; Zhang X; Ni Y; Van Hecke P; Yu J; Baert AL Magn Reson Imaging; 1993; 11(5):665-74. PubMed ID: 8345781 [TBL] [Abstract][Full Text] [Related]
34. Liver-specific contrast media for MRI and CT experimental studies. Leander P Acta Radiol Suppl; 1995; 396():1-36. PubMed ID: 7839867 [TBL] [Abstract][Full Text] [Related]